Lupin Gets FDA Approval to Market Generic Birth Control Pills in US

by Kathy Jones on  December 20, 2012 at 8:53 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

Lupin Pharmaceuticals has finally received the approval from the US Food and Drug Administration to market its oral contraceptive pills in the United States.
 Lupin Gets FDA Approval to Market Generic Birth Control Pills in US
Lupin Gets FDA Approval to Market Generic Birth Control Pills in US

The pills are a generic version of Yasmin, manufactured by Bayer Healthcare, and allows Lupin to carve a slice of the oral contraceptive market which has been growing at a rate of nearly 10 percent every year in the United States.

Conservative estimates by analysts predict that Lupin will be able to gain a 10 percent market share for the pills, potentially earning them over $27 million in annual sales.

The Mumbai-based drug maker released a statement saying, "Lupin will be marketing its Drospirenone and Ethinyl Estradiol tablets USP in a wallet pack of 28 tablets consisting of 21 yellow active tablets, each containing 3 mg Drospirenone and 0.03 mg Ethinyl Estradiol, and 7 white inert tablets."


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Birth Control Pills Vaginitis Vasectomy Birth Control Patch Safe, Effective Male Contraceptive Pill - The Long Wait Popular Sexual Myths Birth Control Pills to Delay Periods 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive